783 648

Cited 0 times in

Cited 103 times in

NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma

DC Field Value Language
dc.contributor.author박은성-
dc.date.accessioned2015-04-23T17:45:09Z-
dc.date.available2015-04-23T17:45:09Z-
dc.date.issued2010-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/103063-
dc.description.abstractBACKGROUND: Myc is a well known driver of lymphomagenesis, and Myc-activating chromosomal translocation is the recognized hallmark of Burkitt lymphoma, an aggressive form of non-Hodgkin's lymphoma. We developed a model that mimics this translocation event by inserting a mouse Myc cDNA gene into the immunoglobulin heavy chain locus, just upstream of the intronic Emu enhancer. These mice, designated iMyc E mu, readily develop B-cell lymphoma. To study the mechanism of Myc-induced lymphoma, we analyzed signaling pathways in lymphoblastic B-cell lymphomas (LBLs) from iMyc E mu mice, and an LBL-derived cell line, iMyc E mu-1. RESULTS: Nuclear factor-kappaB (NF-kappaB) and signal transducer and activator of transcription 3 (STAT3) were constitutively activated in iMyc E mu mice, not only in LBLs but also in the splenic B-lymphocytes of young animals months before tumors developed. Moreover, inhibition of either transcription factor in iMyc E mu-1 cells suppressed growth and caused apoptosis, and the abrogation of NF-kappaB activity reduced DNA binding by both STAT3 and Myc, as well as Myc expression. Inhibition of STAT3 signaling eliminated the activity of both NF-kappaB and Myc, and resulted in a corresponding decrease in the level of Myc. Thus, in iMyc E mu-1 cells NF-kappaB and STAT3 are co-dependent and can both regulate Myc. Consistent with this, NF-kappaB and phosphorylated STAT3 were physically associated with one another. In addition, LBLs and iMyc E mu-1 cells also showed constitutive AKT phosphorylation. Blocking AKT activation by inhibiting PI3K reduced iMyc E mu-1 cell proliferation and caused apoptosis, via downregulation of NF-kappaB and STAT3 activity and a reduction of Myc levels. Co-treatment with NF-kappaB, STAT3 or/and PI3K inhibitors led to additive inhibition of iMyc E mu-1 cell proliferation, suggesting that these signaling pathways converge. CONCLUSIONS: Our findings support the notion that constitutive activation of NF-kappaB and STAT3 depends on upstream signaling through PI3K, and that this activation is important for cell survival and proliferation, as well as for maintaining the level of Myc. Together, these data implicate crosstalk among NF-kappaB, STAT3 and PI3K in the development of iMyc E mu B-cell lymphomas.-
dc.description.statementOfResponsibilityopen-
dc.format.extent97-
dc.relation.isPartOfMOLECULAR CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAnimals-
dc.subject.MESHApoptosis/physiology-
dc.subject.MESHBlotting, Western-
dc.subject.MESHCell Line, Tumor-
dc.subject.MESHDNA Fragmentation-
dc.subject.MESHDisease Models, Animal-
dc.subject.MESHElectrophoretic Mobility Shift Assay-
dc.subject.MESHEnhancer Elements, Genetic-
dc.subject.MESHEnzyme Activation/physiology-
dc.subject.MESHEnzyme-Linked Immunosorbent Assay-
dc.subject.MESHGene Expression/genetics-
dc.subject.MESHGene Expression Regulation, Neoplastic/genetics-
dc.subject.MESHGenes, Immunoglobulin Heavy Chain-
dc.subject.MESHGenes, myc-
dc.subject.MESHImmunoprecipitation-
dc.subject.MESHLymphoma,B-Cell/genetics-
dc.subject.MESHLymphoma,B-Cell/metabolism*-
dc.subject.MESHMice-
dc.subject.MESHNF-kappaB/genetics-
dc.subject.MESHNF-kappaB/metabolism*-
dc.subject.MESHPhosphatidylinositol 3-Kinases/genetics-
dc.subject.MESHPhosphatidylinositol 3-Kinases/metabolism*-
dc.subject.MESHReceptor Cross-Talk/physiology*-
dc.subject.MESHReverse Transcriptase Polymerase Chain Reaction-
dc.subject.MESHSTAT3Transcription Factor/genetics-
dc.subject.MESHSTAT3Transcription Factor/metabolism*-
dc.subject.MESHSignal Transduction/genetics*-
dc.titleNF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma-
dc.typeArticle-
dc.contributor.collegeResearcher Institutes (부설 연구소)-
dc.contributor.departmentInstitute for Medical Convergence (연의-생공연 메디컬융합연구소)-
dc.contributor.googleauthorJoo Hyun Nam-
dc.contributor.googleauthorDong Hun Shin-
dc.contributor.googleauthorJung Eun Min-
dc.contributor.googleauthorSang-Kyu Ye-
dc.contributor.googleauthorJu-Hong Jeon-
dc.contributor.googleauthorSung Joon Kim-
dc.identifier.doi10.1186/1476-4598-9-97-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01609-
dc.relation.journalcodeJ03200-
dc.identifier.eissn1476-4598-
dc.identifier.pmid20433747-
dc.subject.keywordReverse Transcription Polymerase Chain Reaction-
dc.subject.keywordElectrophoretic Mobility Shift Assay-
dc.subject.keywordPI3K Signaling-
dc.subject.keywordSignaling Crosstalk-
dc.subject.keywordSpleen Masse-
dc.contributor.alternativeNamePark, Eun Sung-
dc.contributor.affiliatedAuthorPark, Eun Sung-
dc.citation.volume9-
dc.citation.startPage97-
dc.identifier.bibliographicCitationMOLECULAR CANCER, Vol.9 : 97, 2010-
Appears in Collections:
1. College of Medicine (의과대학) > Research Institute (부설연구소) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.